Cryoglobulinemia and cutaneous vasculitis
Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients
Clinically practical blood volume assessment with fluorescein-labeled HES
Expression of Fas and Fas ligand on spleen T cells of experimental animals after unmodified or leukoreduced allogeneic blood transfusions
Identification of the Kna/Knb polymorphism and a method for Knops genotyping
Evidence that Hy– RBCs express weak Joa antigen
Alteration of amino acid residues at the L-chain N-terminus and in complementarity-determining region 3 increases affinity of a recombinant F(ab) for the human N blood group antigen
Improved method for fluorescence cytometric immunohematology testing
Clinical significance of anti-Jra
Effect of holding buffy coats 4 or 18 hours before preparing pooled filtered PLT concentrates in plasma
New insulation technology provides next-generation containers for “iceless” and lightweight transport of RBCs at 1 to 10°C in extreme temperatures for over 78 hours
The cost-effectiveness of screening blood donors for malaria by PCR
Pediatric large-volume leukapheresis
The translocation of marrow MNCs after experimental myocardial cryoinjury is proportional to the infarcted area
Retention of cellular properties of PBPCs following liquid storage and cryopreservation
Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy
Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking
High prevalence of GBV-C/HGV among relatives of GBV-C/HGV-positive blood donors in blood recipients and in patients with aplastic anemia
Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV
Inhibition of xenogeneic GVHD by PEN110 treatment of donor human PBMNCs
Inactivation of mycoplasma species in blood by INACTINE PEN110 process
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation
Lack of the Cromer antigen GUTI in Mexican Americans and Choctaw Indians
HCV core antigen as an alternative to NAT to detect HCV viremia